%0 Journal Article
%T Essential Thrombocytosis and Fatal Coronary Graft Occlusion: A Case Report
%A Joseph L. Blidgen
%A Clarence D. McGaw
%J World Journal of Cardiovascular Surgery
%P 187-191
%@ 2164-3210
%D 2020
%I Scientific Research Publishing
%R 10.4236/wjcs.2020.1010021
%X Essential thrombocytosis (ET) is a rare myeloproliferative disorder,
which is a major risk factor for thrombosis and bleeding, which complicates
cardiovascular surgery. ET is a risk factor for coronary artery disease that
should be treated. We present a case of a male with ET who underwent coronary
artery bypass grafting (CABG) at the University Hospital of the West Indies,
and died post-surgery. Post mortem revealed early graft thrombosis. We believe
that post<span style=\"font-family:Verdana;\">-</span><span style=\"font-family:Verdana;\">operative aspirin therapy maybe would have prevented this fatal outcome.</span>
%K Thrombocytosis
%K Graft Occlusion
%K Coronary Artery Bypass Grafting
%U http://www.scirp.org/journal/PaperInformation.aspx?PaperID=103631